Cartesian Therapeutics, Inc. — Director's Dealing 2017

Jul 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2017-07-07

Reporting Person: Abraham David (GC and Corporate Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-07	Stock Option (Right to Buy)	$19.33	A	20000	Acquired	2027-07-06	Common Stock (20000)	Direct

Footnotes

F1: This option vests as to 25% of the shares on June 16, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.